ASMB analyst estimates
Assembly Biosciences (ASMB) analyst ratings, the average price target and its range, and every firm's latest call.
ASMB analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 1, 2026 | UBS | UBS Starts Assembly Biosciences (ASMB) at Buy | $52.00 |
| Sep 1, 2026 | Mizuho Securities | Assembly Biosciences price target raised to $53 from $45 at Mizuho | $53.00 |
| Aug 18, 2026 | H.C. Wainwright | H.C. Wainwright Reiterates Buy Rating on Assembly Biosciences (ASMB) | $50.00 |
| Jun 15, 2026 | Mizuho Securities | Assembly Biosciences price target raised to $45 from $40 at Mizuho | $45.00 |
| Nov 20, 2025 | Mizuho Securities | Assembly Biosciences price target raised to $40 from $29 at Mizuho | $40.00 |
| Sep 24, 2025 | JMP Securities | Assembly Biosciences initiated with an Outperform at Citizens JMP | $38.00 |
| Sep 24, 2024 | Mizuho Securities | Mizuho Reiterates Outperform Rating on Assembly Biosciences (ASMB) | $36.00 |
| Sep 20, 2024 | Jefferies | Jefferies Upgrades Assembly Biosciences (ASMB) to Buy | $35.00 |
- 4 firms rate ASMB: 4 buy, 0 hold, 0 sell.
- The average price target is $51.67 from 3 analysts, from $50.00 to $53.00.
Updated 2026-11-06 11:42 UTC